Amal G.
- Country
- France
- Department
- Oncologie médicale
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in advancing diagnostic approaches for triple-negative breast cancer (TNBC), with particular emphasis on early-stage disease detection and treatment response assessment.
- Advanced Imaging Technologies
- Molecular Diagnostics
- Treatment Response Prediction
A key focus lies in utilizing PET/CT imaging techniques for breast cancer evaluation.
Molecular Imaging
The investigator explores innovative applications of 68Ga-FAPI-46 PET/CT imaging in oncology, particularly focusing on its role in evaluating fibroblast activation protein (FAP) expression in tumors.
- Biomarker Development
- Tumor Burden Assessment
- Treatment Monitoring
Research interests include quantitative imaging biomarkers for cancer assessment.
Therapeutic Response
The investigator studies predictive factors in neoadjuvant chemotherapy response, incorporating modern immunotherapy approaches in breast cancer treatment.
- Histological Response Prediction
- Immunotherapy Integration
- Treatment Optimization
Areas of focus include the development of predictive tools for treatment outcomes in oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.